Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Pravin U. Dugel

Pravin U. Dugel is recorded as CEO, Chairman and Board Member at Ocular Therapeutix, Inc (OCUL). Ocular Therapeutix, Inc reported in an 8-K filed February 22, 2024 that Pravin U. Dugel was appointed Class III director, effective February 21, 2024. Ocular Therapeutix, Inc reported in an 8-K filed February 22, 2024 that Pravin U. Dugel was appointed Executive Chairman, effective February 21, 2024.

“On February 20, 2024, Pravin U. Dugel, M.D., was appointed as Executive Chairman of the Company and as a Class III director, effective as of February 21, 2024, to serve until the 2026 annual meeting of the stockholders of the Company and thereafter until his successor has been duly elected and qualified, or until his earlier death, resignation or removal.”
Ocular Therapeutix, Inc Form 8-K, filed February 22, 2024 · Read the filing
“On February 20, 2024, Pravin U. Dugel, M.D., was appointed as Executive Chairman of the Company and as a Class III director, effective as of February 21, 2024, to serve until the 2026 annual meeting of the stockholders of the Company and thereafter until his successor has been duly elected and qualified, or until his earlier death, resignation or removal.”
Ocular Therapeutix, Inc Form 8-K, filed February 22, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Ocular Therapeutix, Inc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.